Home›Search›EPMA Journal

EPMA Journal

BioMed Central Ltd · United Kingdom · Est. 2004

ISSN1878-5077eISSN1878-5085

SJR Q1✓ WOS SCIE✓ Scopus / SJR

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (3 more)+18

⚠ Withdrawn from DOAJ-15

Total81

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

Removed from DOAJ (2017-01-06). DOAJ's stated reason: Journal is not open access. A removal from the Directory of Open Access Journals is a quality/transparency signal — it can mean the journal became inactive or failed DOAJ's re-review criteria. This is not proof of predatory practice, but verify the journal's current status and policies before submitting. Check on DOAJ ↗

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

Publication speed: not measurable

publisher doesn’t disclose per-article submission dates — we never estimate

SJR Rank

Top 25% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei

1.545

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

1.344

Total Worksi

779

Total Citationsi

22,013

2yr Mean Citednessi

6.87

Open Impact Factor alternative

Aims & Scope

EPMA Journal publishes results and achievements in primary (individualised protection of healthy persons against health-to-disease transition) and secondary (individualised protection against disease progression) care Focused on paradigm change from reactive medicine to cost-effective predictive approach, targeted prevention and treatments tailored to the person. This type of research and medical care is complex and requires multi-professional expertise. Application of patient-friendly non-invasive diagnostics and innovative treatment algorithms tailored to the individualised patient profile is envisaged. Innovative technology development follows the concept “From Bench to Bedside”. Official journal of the European Association for Predictive, Preventive and Personalized Medicine, EPMA, Brussels.

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published2004

FrequencyFour No. A Year

StatusActive (last: 2026)

Total Publications779

Publisher OrgSpringer Nature

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

BioMed Central Ltd

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1878-5077 / 1878-5085

✅

Indexed in a trusted database?

WoS, Scopus, PubMed

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

1.8k

2019

1.8k

2020

1.6k

2021

1.1k

2022

975

2023

620

2024

209

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Biochemistry (medical)Q1

Drug DiscoveryQ1

Health PolicyQ1

Subject Classification

Web of Science Categories

Medicine, Research & Experimental

Scopus Categories

Drug DiscoveryBiochemistry (medical)Health Policy

Research Topics (OpenAlex)

Retinal Diseases and TreatmentsGlaucoma and retinal disordersCardiovascular Health and Risk FactorsNutrition, Genetics, and DiseaseRetinal Imaging and AnalysisHealth, Environment, Cognitive AgingGut microbiota and healthHealth Systems, Economic Evaluations, Quality of LifeFerroptosis and cancer prognosisBioinformatics and Genomic Networks

Frequently asked questions about EPMA Journal

Is EPMA Journal a predatory journal?

EPMA Journal was withdrawn from the Directory of Open Access Journals (DOAJ) — DOAJ's stated reason: "Journal is not open access" (2017-01-06). Withdrawal is not a predatory verdict, but it is a material editorial signal; it remains indexed in Web of Science, Scopus. Verify the journal's current status on DOAJ and its official site before submitting.

What is the impact factor of EPMA Journal?

EPMA Journal is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 6.87.

Is EPMA Journal indexed in Scopus and Web of Science?

EPMA Journal is indexed in Web of Science, Scopus.